Detalhe da pesquisa
1.
Over-expression of COX-2 mRNA in colorectal cancer.
BMC Gastroenterol
; 14: 1, 2014 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24383454
2.
Celecoxib and tauro-ursodeoxycholic acid co-treatment inhibits cell growth in familial adenomatous polyposis derived LT97 colon adenoma cells.
Exp Cell Res
; 318(7): 819-27, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22366264
3.
The influence of curcumin, quercetin, and eicosapentaenoic acid on the expression of phase II detoxification enzymes in the intestinal cell lines HT-29, Caco-2, HuTu 80, and LT97.
Nutr Cancer
; 64(6): 856-63, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22830632
4.
Management of sporadic duodenal adenomas and the association with colorectal neoplasms: a retrospective cohort study.
J Clin Gastroenterol
; 46(5): 390-6, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22178960
5.
Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis.
Int J Colorectal Dis
; 26(5): 575-82, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21243500
6.
Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls.
Orphanet J Rare Dis
; 8: 181, 2013 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24245549
7.
Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial.
Orphanet J Rare Dis
; 8: 118, 2013 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23919274
8.
Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: a nationwide retrospective cohort study.
Surgery
; 151(5): 681-90, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22265391